Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. - Wikidata - awgldk - TriplyDB

Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis.

Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis.

http://www.wikidata.org/entity/Q39747558

about

Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA)Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration Laser photocoagulation for neovascular age-related macular degeneration The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia Complement in age-related macular degeneration: a focus on function Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications Polypoidal Choroidal Vasculopathy in Asians Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye A systematic review of overweight, obesity, and type 2 diabetes among Asian American subgroups Genetics of immunological and inflammatory components in age-related macular degeneration Age-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air)Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study.Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration Current and emerging therapies for the treatment of age-related macular degeneration Variation in genetic admixture and population structure among Latinos: the Los Angeles Latino eye study (LALES).Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases.Psychosocial risk factors and retinal microvascular signs: the multi-ethnic study of atherosclerosis Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study.Emphysema, airflow limitation, and early age-related macular degeneration.A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy.The inhibition of NOTCH2 reduces UVB-induced damage in retinal pigment epithelium cells.Prevalence of early and late age-related macular degeneration in India: the INDEYE study.An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism.Is renal function associated with early age-related macular degeneration?The prevalence of age-related macular degeneration and associated risk factors Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis.Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: A systematic review of reviews.Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study Age-related macular degeneration: genetic and environmental factors of disease Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.Age-related macular degeneration: genetics and biology coming together.Improving access to optometry services for people at risk of preventable sight loss: a qualitative study in five UK locations.

P2860

Q21092322-C215E44E-52CC-4652-86CA-E9ABFBFD2405 Q24243234-2906EA7E-2751-4ECA-A32C-8703A513AF40 Q24244141-173FB1DC-DA0F-4DEF-897A-DDF520BA54E7 Q24601205-A15AA938-7E71-432E-BE9A-6FB629FC4BDA Q24635874-B7CBFBAB-3155-404E-9ABD-3C15062EB197 Q24681724-825B6356-9FA4-4428-B629-8986A71C0895 Q26799548-1E31ACA4-C21D-414A-8BDD-27206C7D4588 Q26821899-2139D06E-D08A-4BA9-BC33-062748C51FB7 Q26824174-27EF0A3C-A84B-4887-80E4-B8D250054DDD Q26849231-1D0ECAD1-5E42-4220-8226-11B892C34C3D Q28386582-8A69BC78-0112-4415-8386-04EF5D89405D Q28394334-6FC144A3-BF10-4CEC-A000-E9281F4714BA Q28540642-FBD1806A-A5BF-4575-8B68-6A50E5A94226 Q31015035-D14E4085-D4A8-49BB-8908-EA9050B6D85E Q31143690-6D0D449A-2C9D-4C06-A8AD-31D78B1E01CE Q33290721-6D86141E-BC2D-48E7-83DE-808EB4E9DE12 Q33341495-85FA13F1-DA8E-4F5F-BCD5-F24564E3B59B Q33492370-3B336660-DDB8-4FAD-9CEE-A8B1DE8F3DD3 Q33515702-DB5CC9B9-217D-434C-8A04-F5DA5E03C39E Q33577384-40AFD987-F2B1-46B5-B2E8-DC31C48B4C85 Q33686810-F287F131-1EFC-41B1-99F5-D511FC3F0EF7 Q33741587-4DF975B1-F724-4E13-83C1-2BB3FEDAC9E8 Q33759162-A7BD9BA8-914E-4A95-937D-C86A456F6BA5 Q33791622-AAC725BA-34BA-4194-BC18-12AC6D077951 Q33825750-9201BE21-DF98-4812-9C90-B64F9A649E23 Q33828306-36279EFE-8147-4AB4-9E3F-0B8A6730B7E7 Q33845354-7AE3E59D-7F36-4B27-8C01-267AEA1496DB Q33845500-3115CE66-9412-46B4-AF22-FDE89C2B8EA8 Q33953345-8A2F6484-1897-4B3A-9DFD-68210ECE7830 Q33957918-DC234A1A-0671-4E70-9367-82E0F518A26F Q34062494-6F0C03D0-51CB-4FD6-BBCB-36D0F55E0AB3 Q34090408-796A923F-9C27-4354-9DF5-C5DE5548BF9F Q34111156-CA087406-1E11-41B9-BB46-F503222F26EC Q34114772-DBCF96B0-F288-4F5D-B3C3-724C1EEAA229 Q34124000-0EED6720-F06F-4D51-AF97-4B68AAA1DFDC Q34213760-839EFFEA-24B8-4B94-B18F-070F099D15EA Q34407622-404ABD4C-033D-4C7C-88E2-05A3977DA824 Q34437319-D0E92456-811A-4776-B2DC-C82876770671 Q34440797-A179DE55-8E0E-4C63-A844-DF9F4739C0CC Q34579546-E953FDAA-7C47-4A6D-93CF-0AA5EDBBF825

P2860

Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis.

http://www.wikidata.org/entity/Q39747558

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@en

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@nl

type

label

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@en

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@nl

prefLabel

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@en

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@nl

P1433

Q39747558-7480912A-4CAE-44E0-A4D7-43C826DB7AC2

P1476

Q39747558-03AD7A79-5863-441E-8789-55FE20831D8C

P2093

Q39747558-5B23467F-302C-4010-BEC3-F235B508CBFE

Q39747558-9BC226BC-E88E-4AAC-A84F-A0E5FDFFB327

Q39747558-A9C18348-280F-4450-BEAC-866DC3899608

Q39747558-B6D56C68-517A-40FD-8C39-C3CD7B1AD22E

Q39747558-BBD1A27F-7120-4F46-B025-F0A75A648D6E

Q39747558-C2060B6B-7859-4C45-8043-1BE828F58730

Q39747558-F68D4365-1886-40F3-9E3C-AC7B931B27EA

Q39747558-F8F944C7-00BF-4878-B829-F90D7898D177

P304

Q39747558-14EF2E1D-85DB-48D8-B8D5-7F5075C64A9A

P31

Q39747558-2B62461B-A525-4636-9A72-E6B2F7E166DB

P356

Q39747558-E3689231-E3AB-453A-B4F5-2BEC39A13FE7

P433

Q39747558-B0615474-9705-45FD-B4A8-C6A117DD20D4

P478

Q39747558-2F5B78F6-76A4-49E0-BFAF-F136F653301A

P50

Q39747558-52D2B680-CDCB-4311-B7C3-24A89AE41C9B

P577

Q39747558-0589E150-1268-4FC2-B245-38115213241D

P698

Q39747558-34E5A2ED-F1D5-4645-B54B-335EF840709E

P921

Q39747558-5927566D-DE33-4015-9B50-C401D594D36A

P356

J.OPHTHA.2005.12.013

P1433

P1476

Prevalence of age-related macu ...... hnic study of atherosclerosis.

@en

P2093

Barbara E K Klein

http://www.w3.org/2001/XMLSchema#string

David R Jacobs

http://www.w3.org/2001/XMLSchema#string

Gregory Burke

http://www.w3.org/2001/XMLSchema#string

Kiang Liu

http://www.w3.org/2001/XMLSchema#string

Michael D Knudtson

http://www.w3.org/2001/XMLSchema#string

Mohammed F Saad

http://www.w3.org/2001/XMLSchema#string

Ronald Klein

http://www.w3.org/2001/XMLSchema#string

Tien Yin Wong

http://www.w3.org/2001/XMLSchema#string

P304

373-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2005.12.013

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Mary Frances Cotch

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16513455

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis